3,121
Views
11
CrossRef citations to date
0
Altmetric
Review

Expert review with meta-analysis of randomized and nonrandomized controlled studies of Barricaid annular closure in patients at high risk for lumbar disc reherniation

, , &
Pages 461-469 | Received 14 Feb 2020, Accepted 17 Mar 2020, Published online: 01 Apr 2020

Figures & data

Figure 1. Schematic of the Barricaid Annular Closure Device (left) and lateral radiograph showing the Barricaid Annular Closure Device implanted at L4-L5 (right).

Figure 1. Schematic of the Barricaid Annular Closure Device (left) and lateral radiograph showing the Barricaid Annular Closure Device implanted at L4-L5 (right).

Figure 2. CONSORT patient flow diagram.

Figure 2. CONSORT patient flow diagram.

Table 1. Compendium of 50 peer-reviewed manuscripts of the Barricaid device for annulus fibrosus closure.

Table 2. Patient and study characteristics in controlled studies with the Barricaid device for annulus fibrosus closure.

Table 3. Risk of bias in controlled studies with the Barricaid device for annulus fibrosus closure.

Figure 3. Symptomatic reherniation within 2 years in controlled studies of lumbar discectomy with or without the Barricaid Annular Closure Device. The risk ratio = 0.45 (p < 0.001), which indicates a 55% risk reduction with the Barricaid device.

Figure 3. Symptomatic reherniation within 2 years in controlled studies of lumbar discectomy with or without the Barricaid Annular Closure Device. The risk ratio = 0.45 (p < 0.001), which indicates a 55% risk reduction with the Barricaid device.

Figure 4. Reoperations within 2 years in controlled studies of lumbar discectomy with or without the Barricaid Annular Closure Device. The risk ratio = 0.52 (p = 0.003), which indicates a 48% risk reduction with the Barricaid device.

Figure 4. Reoperations within 2 years in controlled studies of lumbar discectomy with or without the Barricaid Annular Closure Device. The risk ratio = 0.52 (p = 0.003), which indicates a 48% risk reduction with the Barricaid device.